Fisher & Paykel Healthcare Corporation Limited (FSPKF)

Market Cap	12.65B
Revenue (ttm)	1.25B
Net Income (ttm)	253.41M
Shares Out	n/a
EPS (ttm)	0.43
PE Ratio	49.93
Forward PE	44.71
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1,119
Open	23.00
Previous Close	23.00
Day's Range	23.00 - 23.00
52-Week Range	16.35 - 23.00
Beta	0.74
RSI	55.83
Earnings Date	Nov 25, 2025

About FSPKF

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilatio...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1934
• Employees: 7,440
• Stock Exchange: OTCMKTS
• Ticker Symbol: FSPKF

Financial Performance

In 2024, FSPKF's revenue was 2.02 billion, an increase of 15.96% compared to the previous year's 1.74 billion. Earnings were 377.20 million, an increase of 184.46%.

Financial numbers in NZD